Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02404194 · ClinicalTrials.gov registry record · NA
Targeted Cognitive Training in Clinical High Risk (CHR) for Psychosis
A NA study of Clinical High Risk for Psychosis, sponsored by Rush University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 139
- Enrollment target
- 1
- Study location
NCT02404194: Completed NA study of Clinical High Risk for Psychosis, sponsored by Rush University Medical Center.
NCT02404194 is a NA study of Clinical High Risk for Psychosis that has completed, run by Rush University Medical Center. The registered enrollment target is 139 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02404194, a NA study of Clinical High Risk for Psychosis, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 139 participants
- Enrollment target
- 1
- Study location
Study Summary
This project is a randomized-controlled trial to test the efficacy of computer-based targeted cognitive training (TCT) versus a placebo intervention of commercial computer games in adolescent/young adults at clinical high risk (CHR) for psychosis. TCT is designed to optimize learning-induced neuroplasticity in vulnerable neurocognitive systems. A main aim is to test the hypothesis that this neuroscience-guided TCT intervention will improve neural function, and that these neural improvements will improve cognition and functional outcome. CHR participants will be randomly assigned to 40 hours of TCT or placebo computer games completed within 10 weeks. TCT consists of 20 hours of training in cognition, including processing speed, memory, attention, and cognitive control followed by 20 hours of training in social cognition including affect recognition and theory of mind. Neuroimaging, cognition, social cognition, clinical symptoms, and functional status will be assessed at baseline, after 20 hours/5 weeks of cognitive training (mid-intervention), and after 20 hours/5 weeks of social-cognitive training (post-intervention). Cognition, social cognition, symptoms, and functioning will also be assessed at a 9 month follow-up (i.e. 9 months after intervention completion). We predict that TCT will lead to improvements in neurocognitive function and functional status. The results of this study will provide important information about a benign, non-pharmacological intervention for improving cognition and functional outcome in CHR individuals.
Primary Outcome
Behavioral assessment of cognition
Conditions Studied
Interventions
- BEHAVIORAL Targeted Cognitive Training
- BEHAVIORAL Computer Games
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2015-03 |
| Est. Completion | 2021-02-15 |
| Phase | NA |
What the finished NCT02404194 record still lists
NCT02404194 is an interventional study that assigns participants to a tested intervention. The registered 139 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Clinical High Risk for Psychosis appearing as the primary indexed condition, and to 2 interventions - of which Targeted Cognitive Training is the first listed.
NCT02404194 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT02404194 about?
NCT02404194 is a clinical study titled "Targeted Cognitive Training in Clinical High Risk (CHR) for Psychosis". This project is a randomized-controlled trial to test the efficacy of computer-based targeted cognitive training (TCT) versus a placebo intervention of commercial computer games in adolescent/young adults at clinical high risk (CHR) for psychosis. TCT is designed to optimize learning-induced neuropl...
What is the current status of trial NCT02404194?
This trial is currently completed. It is a NA study. The enrollment target is 139 participants. The study started on 2015-03. Estimated completion is 2021-02-15.
What conditions does trial NCT02404194 study?
This clinical trial studies the following conditions: Clinical High Risk for Psychosis.
What interventions are being tested in trial NCT02404194?
The interventions under investigation include: Targeted Cognitive Training (BEHAVIORAL), Computer Games (BEHAVIORAL).
Who is sponsoring clinical trial NCT02404194?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02404194 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Clinical High Risk for Psychosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02404194's enrollment target sits among peer trials
139 720th of 2000 higher than 1,281 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05645380 · 139 participants · Phase 2
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
- NCT06239272 · 139 participants · Phase 1
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- NCT06252220 · 139 participants · Phase 1
First in Human Study in Subjects With Obesity, But Otherwise Healthy
- NCT06537128 · 139 participants · NA
Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia